PetMed Express, Inc. - stock earnings
PETS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -70000 USD | 71.0 million USD |
| 2023Q2 | -887000 USD | 78.2 million USD |
| 2023Q1 | -5.1 million USD | 62.4 million USD |
| 2022Q4 | -19000 USD | 58.9 million USD |
| 2022Q3 | 2.6 million USD | 65.4 million USD |
| 2022Q2 | 2.8 million USD | 70.2 million USD |
| 2022Q1 | 6.1 million USD | 66.0 million USD |
| 2021Q4 | 4.3 million USD | 60.7 million USD |
| 2021Q3 | 6.3 million USD | 67.4 million USD |
| 2021Q2 | 4.4 million USD | 79.3 million USD |
| 2021Q1 | 6.8 million USD | 71.7 million USD |
| 2020Q4 | 7.6 million USD | 65.9 million USD |
| 2020Q3 | 8.4 million USD | 75.4 million USD |
| 2020Q2 | 7.8 million USD | 96.2 million USD |
| 2020Q1 | 7.0 million USD | 74.3 million USD |
| 2019Q4 | 6.8 million USD | 59.9 million USD |
| 2019Q3 | 6.7 million USD | 69.9 million USD |
| 2019Q2 | 5.3 million USD | 80.0 million USD |
| 2019Q1 | 6.6 million USD | 64.6 million USD |
| 2018Q4 | 7.8 million USD | 60.1 million USD |
| 2018Q3 | 10.8 million USD | 71.4 million USD |
| 2018Q2 | 12.6 million USD | 87.4 million USD |
| 2018Q1 | 10.2 million USD | 67.3 million USD |
| 2017Q4 | 9.1 million USD | 60.1 million USD |
| 2017Q3 | 8.8 million USD | 66.7 million USD |
| 2017Q2 | 9.3 million USD | 79.7 million USD |
| 2017Q1 | 7.5 million USD | 63.0 million USD |
| 2016Q4 | 4.8 million USD | 52.9 million USD |
| 2016Q3 | 4.9 million USD | 60.8 million USD |
| 2016Q2 | 6.6 million USD | 72.5 million USD |
| 2016Q1 | 5.4 million USD | 55.4 million USD |
| 2015Q4 | 4.9 million USD | 50.9 million USD |
| 2015Q3 | 4.5 million USD | 56.7 million USD |
| 2015Q2 | 5.8 million USD | 71.6 million USD |
| 2015Q1 | 5.0 million USD | 50.0 million USD |
| 2014Q4 | 4.8 million USD | 49.3 million USD |
| 2014Q3 | 2.7 million USD | 57.6 million USD |
| 2014Q2 | 5.0 million USD | 72.5 million USD |
| 2014Q1 | 4.5 million USD | 48.6 million USD |
| 2013Q4 | 4.5 million USD | 50.1 million USD |
| 2013Q3 | 4.2 million USD | 60.5 million USD |
| 2013Q2 | 4.8 million USD | 74.2 million USD |
| 2013Q1 | 4.6 million USD | 51.1 million USD |
| 2012Q4 | 4.6 million USD | 49.6 million USD |
| 2012Q3 | 4.0 million USD | 58.1 million USD |
| 2012Q2 | 4.0 million USD | 69.0 million USD |
| 2012Q1 | 4.0 million USD | 55.9 million USD |
| 2011Q4 | 3.9 million USD | 50.5 million USD |
| 2011Q3 | 3.9 million USD | 58.2 million USD |
| 2011Q2 | 4.8 million USD | 73.6 million USD |
| 2011Q1 | 4.1 million USD | 50.9 million USD |
| 2010Q4 | 4.5 million USD | 45.1 million USD |
| 2010Q3 | 5.0 million USD | 61.2 million USD |
| 2010Q2 | 7.2 million USD | 74.4 million USD |
| 2010Q1 | 6.1 million USD | 50.3 million USD |
| 2009Q4 | 5.6 million USD | 48.4 million USD |
| 2009Q3 | 6.3 million USD | 62.4 million USD |
| 2009Q2 | 8.1 million USD | 77.2 million USD |
| 2009Q1 | 5.6 million USD | 48.1 million USD |
| 2008Q4 | 4.9 million USD | 43.4 million USD |
| 2008Q3 | 5.8 million USD | 59.6 million USD |
| 2008Q2 | 6.6 million USD | 68.4 million USD |
| 2008Q1 | 4.9 million USD | 40.4 million USD |
| 2007Q4 | 4.4 million USD | 37.3 million USD |
| 2007Q3 | 4.5 million USD | 51.5 million USD |
| 2007Q2 | 6.2 million USD | 59.0 million USD |
| 2007Q1 | 3.6 million USD | 36.4 million USD |
| 2006Q4 | 2.8 million USD | 31.4 million USD |
| 2006Q3 | 3.3 million USD | 43.8 million USD |
| 2006Q2 | 4.8 million USD | 50.7 million USD |
| 2006Q1 | 3.1 million USD | 29.4 million USD |
| 2005Q4 | 2.7 million USD | 25.9 million USD |
| 2005Q3 | 2.7 million USD | 38.7 million USD |
| 2005Q2 | 3.5 million USD | 43.6 million USD |
| 2005Q1 | 2.4 million USD | 23.5 million USD |
| 2004Q4 | 2.0 million USD | 20.8 million USD |
| 2004Q3 | 1.8 million USD | 28.8 million USD |
| 2004Q2 | 1.8 million USD | 35.3 million USD |
| 2004Q1 | 1.3 million USD | 21.5 million USD |
| 2003Q4 | 1.2 million USD | 17.2 million USD |
| 2003Q3 | 1.8 million USD | 25.0 million USD |
| 2003Q2 | 1.4 million USD | 30.4 million USD |
| 2003Q1 | 1.7 million USD | 14.9 million USD |
| 2002Q4 | 434710 USD | 11.1 million USD |
| 2002Q3 | 204887 USD | 14.2 million USD |
| 2002Q2 | 902329 USD | 14.8 million USD |
| 2002Q1 | 1.2 million USD | 10.7 million USD |
| 2001Q4 | 353348 USD | 8.2 million USD |
| 2001Q3 | 393378 USD | 7.8 million USD |
| 2001Q2 | -1.1 million USD | 2.9 million USD |
| 2001Q1 | -1.1 million USD | 2.9 million USD |
| 2000Q4 | -364202 USD | 1.8 million USD |
| 2000Q3 | -298602 USD | 2.7 million USD |
| 2000Q2 | -1.3 million USD | 3.1 million USD |
| 2000Q1 | -1.3 million USD | 3.1 million USD |
PETS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 233000 USD | 256.9 million USD |
| 2022 | 21.1 million USD | 273.4 million USD |
| 2021 | 30.6 million USD | 309.2 million USD |
| 2020 | 25.9 million USD | 284.1 million USD |
| 2019 | 37.7 million USD | 283.4 million USD |
| 2018 | 37.3 million USD | 273.8 million USD |
| 2017 | 23.8 million USD | 249.2 million USD |
| 2016 | 20.6 million USD | 234.7 million USD |
| 2015 | 17.5 million USD | 229.4 million USD |
| 2014 | 18.0 million USD | 233.4 million USD |
| 2013 | 17.2 million USD | 227.8 million USD |
| 2012 | 16.7 million USD | 238.3 million USD |
| 2011 | 20.9 million USD | 231.6 million USD |
| 2010 | 26.0 million USD | 238.3 million USD |
| 2009 | 23.0 million USD | 219.4 million USD |
| 2008 | 20.0 million USD | 188.3 million USD |
| 2007 | 14.4 million USD | 162.2 million USD |
| 2006 | 12.1 million USD | 137.6 million USD |
| 2005 | 8.0 million USD | 108.4 million USD |
| 2004 | 5.8 million USD | 94.0 million USD |
| 2003 | 3.3 million USD | 55.0 million USD |
| 2002 | 825413 USD | 32.0 million USD |
| 2001 | -2.8 million USD | 10.0 million USD |
| 2000 | -1.8 million USD | 14.7 million USD |
PETS
Price: $4.11
52 week price:
Dividend Yield: 0.26%
5-year range yield:
Forward Dividend Yield: 14.60%
Payout Ratio: -200.00%
Payout Ratio Range:
Dividend Per Share: 0.60 USD
Earnings Per Share: -0.30 USD
P/E Ratio: -19.57
Exchange: NMS
Sector: Healthcare
Industry: Pharmaceutical Retailers
Volume: 271900
Ebitda: 12.0 millionMarket Capitalization: 94.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 2.97%
DGR5: 4.42%
DGR10: 7.02%